KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bausch Health Companies (BHC) Invested Capital: 2009-2025

Historic Invested Capital for Bausch Health Companies (BHC) over the last 17 years, with Sep 2025 value amounting to $20.5 billion.

  • Bausch Health Companies' Invested Capital fell 3.71% to $20.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $20.5 billion, marking a year-over-year decrease of 3.71%. This contributed to the annual value of $20.3 billion for FY2024, which is 4.82% down from last year.
  • According to the latest figures from Q3 2025, Bausch Health Companies' Invested Capital is $20.5 billion, which was down 2.37% from $21.0 billion recorded in Q2 2025.
  • Over the past 5 years, Bausch Health Companies' Invested Capital peaked at $23.6 billion during Q1 2021, and registered a low of $20.3 billion during Q1 2025.
  • Moreover, its 3-year median value for Invested Capital was $21.0 billion (2025), whereas its average is $21.1 billion.
  • As far as peak fluctuations go, Bausch Health Companies' Invested Capital declined by 11.10% in 2021, and later grew by 5.30% in 2024.
  • Bausch Health Companies' Invested Capital (Quarterly) stood at $22.6 billion in 2021, then decreased by 7.05% to $21.0 billion in 2022, then climbed by 1.62% to $21.4 billion in 2023, then dropped by 4.82% to $20.3 billion in 2024, then dropped by 3.71% to $20.5 billion in 2025.
  • Its Invested Capital stands at $20.5 billion for Q3 2025, versus $21.0 billion for Q2 2025 and $20.3 billion for Q1 2025.